Clin2
NCT05320926Possibly a fitRecruiting

Clopidogrel vs aspirin after heart stent treatment

Ischemic Heart Disease

Part of Heart & circulation clinical trials.

This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,744 people
Ages
19 years to 84 years
Study type
Interventional

Who can take part

  • You are at least 19 years old
  • You recently received a zotarolimus-eluting Onyx drug-eluting heart stent for ischemic (reduced blood flow) heart disease
  • You can sign and understand the informed consent form
  • You are younger than 85 years old
  • You do NOT currently have an acute heart attack

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05305482Recruiting
Compare two stents after heart attack treatment

This trial compares two types of stents that release medicine to help keep arteries open after an acute coronary syndrome event (often called a heart attack or unstable angina). It tests whether the standard short course of two blood-thinning medicines for one month is enough, and which stent strategy works best.

Seoul
NCT05936606Recruiting
Personalized blood thinner choice after stent placement

This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.

Seoul
NCT05418556Recruiting· Phase 4
Comparing antiplatelet strategies after heart stent

This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.

Bucheon-si
NCT07432516Not yet recruiting
Comparing antiplatelet and cholesterol-lowering therapy after heart stent

This study compares different combinations of antiplatelet (blood-thinning for the stent) and cholesterol-lowering (statin) medicines after stent placement for a heart attack or unstable angina. The goal is to find the best way to prevent future heart problems and improve outcomes.

Seoul
NCT06175377Not yet recruiting
Longer vs shorter blood thinners after a heart artery stent

This study looks at whether taking a second blood thinner (clopidogrel) plus aspirin for a longer time helps prevent heart problems after a stent opens a fully blocked artery. It compares two durations of treatment to see which is better for patients like you.

NCT04995159Not yet recruiting
Optimized blood thinner therapy after heart stent placement

This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.

Bengbu, Anhui

Hear when a new Ischemic Heart Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.